Bank of New York Mellon Portfolio holdings
Bank of New York Mellon (BNY Mellon), tracing its origins to 1784 when Alexander Hamilton founded the Bank of New York, is a global financial institution headquartered in New York City, specializing in asset servicing, custody banking, and investment management. As one of the world’s largest custodian banks, it safeguards trillions in assets for institutions like pension funds, mutual funds, and governments, while its investment arm manages billions through subsidiaries like Mellon Investments and Dreyfus. Known for its role as a financial infrastructure backbone, BNY Mellon also provides treasury services, wealth management, and market analytics, blending a rich historical legacy with modern fintech innovations. The 2007 merger of Bank of New York and Mellon Financial solidified its position as a leader in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$980M |
| 2 |
Newmont
NEM
|
+$415M |
| 3 |
Moody's
MCO
|
+$313M |
| 4 |
Uber
UBER
|
+$263M |
| 5 |
AbbVie
ABBV
|
+$255M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$981M |
| 2 |
Microsoft
MSFT
|
+$876M |
| 3 |
HES
Hess
HES
|
+$530M |
| 4 |
ATVI
Activision Blizzard
ATVI
|
+$438M |
| 5 |
Merck
MRK
|
+$432M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.3% |
| 2 | Healthcare | 12.26% |
| 3 | Financials | 11.95% |
| 4 | Consumer Discretionary | 9.9% |
| 5 | Industrials | 8.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4001
Perspective Therapeutics
CATX
$354M
| $62K | ﹤0.01% |
15,424
| – | – |
|
4002
Tempest Therapeutics
TPST
$18.7M
| $61.3K | ﹤0.01% |
+1,072
| New | +$50.8K |
|
4003
Wipro
WIT
$19.4B
| $60.7K | ﹤0.01% |
21,778
-2,480
| -10% | -$6.02K |
|
4004
Heritage Global
HGBL
$37.5M
| $58.9K | ﹤0.01% |
21,180
+6,025
| +40% | +$17.7K |
|
|
CBIO
4005
Crescent Biopharma
CBIO
$618M
| $58.4K | ﹤0.01% |
247
-2
| -0.8% | -$311 |
|
|
LX
4006
LexinFintech Holdings
LX
$236M
| $58.3K | ﹤0.01% |
31,699
-1,507
| -5% | -$2.89K |
|
|
GOEV
4007
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $57.9K | ﹤0.01% |
489
+246
| +101% | +$33.3K |
|
|
ICD
4008
DELISTED
Independence Contract Drilling, Inc.
ICD
| $57.7K | ﹤0.01% |
23,544
-399
| -2% | -$1.03K |
|
4009
RLX Technology
RLX
$2.44B
| $57.4K | ﹤0.01% |
28,720
+6,088
| +27% | +$11.3K |
|
4010
Myomo
MYO
$57.8M
| $56.6K | ﹤0.01% |
+11,294
| New | +$30.1K |
|
4011
1stdibs.com
DIBS
$163M
| $56.5K | ﹤0.01% |
12,075
-105
| -0.9% | -$443 |
|
|
ALUR
4012
DELISTED
Allurion Technologies
ALUR
| $56.3K | ﹤0.01% |
602
| – | – |
|
4013
Citizens
CIA
$198M
| $56K | ﹤0.01% |
20,821
| – | – |
|
|
SOHO
4014
DELISTED
Sotherly Hotels
SOHO
| $54.3K | ﹤0.01% |
36,434
-482
| -1% | -$747 |
|
|
GTHX
4015
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
| $53.7K | ﹤0.01% |
17,607
| – | – |
|
4016
Fortuna Silver Mines
FSM
$3.1B
| $52.9K | ﹤0.01% |
13,701
+169
| +1% | +$565 |
|
4017
Ocugen
OCGN
$458M
| $50.5K | ﹤0.01% |
87,752
| – | – |
|
|
RAIN
4018
DELISTED
Rain Oncology Inc. Common Stock
RAIN
| $50.2K | ﹤0.01% |
41,801
| – | – |
|
4019
Nektar Therapeutics
NKTR
$2.57B
| $48.3K | ﹤0.01% |
5,693
-191
| -3% | -$1.45K |
|
4020
Achieve Life Sciences
ACHV
$744M
| $47.1K | ﹤0.01% |
11,441
| – | – |
|
4021
IHS Holding
IHS
$2.81B
| $47K | ﹤0.01% |
+10,223
| New | +$50.6K |
|
4022
Relmada Therapeutics
RLMD
$507M
| $46.4K | ﹤0.01% |
11,198
-25,521
| -70% | -$75.6K |
|
4023
Atossa Therapeutics
ATOS
$25.5M
| $46K | ﹤0.01% |
3,481
-3,909
| -53% | -$42.2K |
|
|
LL
4024
DELISTED
LL Flooring Holdings, Inc.
LL
| $45.9K | ﹤0.01% |
11,781
-8,193
| -41% | -$27.3K |
|
|
BNKK
4025
Bonk Inc
BNKK
$8.16M
| $45.8K | ﹤0.01% |
+373
| New | +$35.1K |
|
Similar funds
Bank of New York Mellon's Q4 2023 Portfolio in Review
As of Q4 2023, Bank of New York Mellon held 4,468 positions worth $493B, up 8.4% from $455B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Bank of New York Mellon's Q4 2023 filing shows 126 new, 1,615 increased, 2,238 reduced and 158 closed positions. Its largest new stake was Veralto: 3,360,679 shares worth $276M. The largest sale was Apple, an estimated $981M.
By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Financials.
- Bank of New York Mellon's largest Q4 2023 buy was Veralto: 3,360,679 shares worth $276M.
- Bank of New York Mellon added most to iShares Core S&P 500 ETF in Q4 2023, an estimated $980M increase.
- Bank of New York Mellon's biggest Q4 2023 reduction was Apple, cutting an estimated $981M.
- Bank of New York Mellon fully exited Activision Blizzard in Q4 2023, selling an estimated $438M.
- Bank of New York Mellon's ten largest holdings make up 21% of its $493B portfolio in Q4 2023.
- Bank of New York Mellon opened 126 new positions and closed 158 in Q4 2023.
- Bank of New York Mellon's portfolio value rose 8.4% quarter-over-quarter to $493B.
Based on Bank of New York Mellon's 13F filing for Q4 2023, filed 29 Jan 2024.